.
.
.
.

Oil rises above $49 as COVID-19 vaccine release spurs demand hopes

Published: Updated:

Oil rose above $49 a barrel on Thursday as hopes of a faster demand recovery after the release of COVID-19 vaccines offset a huge rise in US crude inventories that showed supply remains ample.

For more coronavirus news, visit our dedicated page.

Britain began vaccinations this week and they could start as soon as this weekend in the United States. Canada on Wednesday approved its first vaccine and said initial shots would be delivered starting next week.

For all the latest headlines follow our Google News channel online or via the app

Brent crude was up 35 cents, or 0.7 percent, to $49.21 a barrel at 0920 GMT, rising for a third day. US West Texas Intermediate (WTI) crude rose 22 cents, or 0.5 percent, to $45.74.

Oil gained even after the latest weekly report on US oil inventories showed a massive, 15.2 million-barrel rise in crude stocks. Analysts had expected a 1.4 million-barrel drop.

“The latest set of data has exceeded any bearish expectations,” said Tamas Varga of oil broker PVM. “The stubbornness of oil bulls and their confidence in the positive economic impact of the vaccine roll-out are truly remarkable.”



Concern over an attack on an Iraqi oilfield also lent support. Two wells at a small field were set ablaze by explosives on Wednesday, but overall production from the field was not affected.

“Traders are also nervous about the oil supply,” said Naeem Aslam of Avatrade, referring to the Iraq attack.



Oil has recovered from historic lows reached in April as the pandemic hammered demand, helped by a record supply-cut deal by the Organization of the Petroleum Exporting Countries and allies, known as OPEC+.

OPEC+ will further ease its level of supply curbs in January by adding an extra 500,000 barrels per day of supply, although the easing is more gradual than previously agreed to provide additional support to the market.